Skip to main content

Abeona Therapeutics Inc.

ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000318306

In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Abeona Therapeutics Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of ABEO: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders7873−5
Shares31.1M27.8M−3.30M (−10.6%)
Value$58.4M$43.4M−$15.0M (−25.7%)

New holders (18)

Institutions that held Abeona Therapeutics Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to ABEO in Q2 2021
InstitutionSharesValue% of portfolio
Millennium Management LLC1,370,101$2.14M0.00%
Highland Capital Management Fund Advisors, L.P.500,000$780.0K0.17%
Phoenix Holdings Ltd.300,000$491.0K0.01%
Tibra Equities Europe Ltd199,700$312.0K0.10%
HRT Financial LP180,835$282.0K0.00%
Ergoteles LLC179,300$280.0K0.01%
Kore Private Wealth LLC77,459$121.0K0.01%
XTX Topco Ltd76,941$120.0K0.04%
LMR Partners LLP38,599$60.0K0.00%
Boothbay Fund Management, LLC24,764$39.0K0.00%
Principal Financial Group Inc22,746$35.0K0.00%
Qube Research & Technologies Ltd22,572$35.0K0.00%
Platform Technology Partners18,506$29.0K0.01%
Y-Intercept (Hong Kong) Ltd15,213$24.0K0.01%
Alpine Global Management, LLC10,911$17.0K0.00%
MML Investors Services, LLC10,000$16.0K0.00%
Quantbot Technologies LP3,200$4.00K0.00%
Eubel Brady & Suttman Asset Management Inc100$00.00%

Sold out (23)

Institutions that held Abeona Therapeutics Inc. at the end of Q1 2021 and filed for Q2 2021 without it.